Harlan Waksal - Net Worth and Insider Trading
Harlan Waksal Net Worth
The estimated net worth of Harlan Waksal is at least $2 Million dollars as of 2023-09-26. Harlan Waksal is the President, CEO of Kadmon Holdings Inc and owns about 152,945 shares of Kadmon Holdings Inc (KDMN) stock worth over $1 Million. Harlan Waksal is also the Executive Chair of Lyra Therapeutics Inc and owns about 236,966 shares of Lyra Therapeutics Inc (LYRA) stock worth over $907,580. Details can be seen in Harlan Waksal's Latest Holdings Summary section.
Transaction Summary of Harlan Waksal
Harlan Waksal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harlan Waksal owns 3 companies in total, including Kadmon Holdings Inc (KDMN) , Eloxx Pharmaceuticals Inc (ELOX) , and Lyra Therapeutics Inc (LYRA) .
Click here to see the complete history of Harlan Waksal’s form 4 insider trades.
Insider Ownership Summary of Harlan Waksal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KDMN | Kadmon Holdings Inc | 2020-09-10 | director & President & CEO |
| ELOX | Eloxx Pharmaceuticals Inc | 2012-05-16 | director |
| LYRA | Lyra Therapeutics Inc | 2022-02-16 | director & Executive Chair |
Harlan Waksal Latest Holdings Summary
Harlan Waksal currently owns a total of 2 stocks. Among these stocks, Harlan Waksal owns 152,945 shares of Kadmon Holdings Inc (KDMN) as of March 13, 2020, with a value of $1 Million and a weighting of 61.55%. Harlan Waksal also owns 236,966 shares of Lyra Therapeutics Inc (LYRA) as of April 12, 2022, with a value of $907,580 and a weighting of 38.45%.
Latest Holdings of Harlan Waksal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| KDMN | Kadmon Holdings Inc | 2020-03-13 | 152,945 | 9.50 | 1,452,978 |
| LYRA | Lyra Therapeutics Inc | 2022-04-12 | 236,966 | 3.83 | 907,580 |
Holding Weightings of Harlan Waksal
Harlan Waksal Form 4 Trading Tracker
According to the SEC Form 4 filings, Harlan Waksal has made a total of 2 transactions in Kadmon Holdings Inc (KDMN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Kadmon Holdings Inc is the acquisition of 16,000 shares on March 13, 2020, which cost Harlan Waksal around $46,880.
According to the SEC Form 4 filings, Harlan Waksal has made a total of 1 transactions in Lyra Therapeutics Inc (LYRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lyra Therapeutics Inc is the acquisition of 236,966 shares on April 12, 2022, which cost Harlan Waksal around $999,996.
Insider Trading History of Harlan Waksal
- 1
Harlan Waksal Trading Performance
GuruFocus tracks the stock performance after each of Harlan Waksal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harlan Waksal is 15.04%. GuruFocus also compares Harlan Waksal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harlan Waksal within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harlan Waksal's insider trading performs compared to the benchmark.
Performance of Harlan Waksal
Average Relative Return
0.83%
Outperforming Transactions
57%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 2.44 | 15.04 | 18.16 | 0.83 | -17.6 | 3.33 |
| Relative Return to S&P 500(%) | 2.26 | 10.03 | 9.74 | -20.83 | -28.15 | -8.51 |
Harlan Waksal Ownership Network
Ownership Network List of Harlan Waksal
Ownership Network Relation of Harlan Waksal
Harlan Waksal Owned Company Details
What does Kadmon Holdings Inc do?
Kadmon Holdings Inc is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of small molecules and biologics with a focus on inflammatory and fibrotic diseases. Its pipeline products include Belumosudil (KD025) and KD033.
Who are the key executives at Kadmon Holdings Inc?
Harlan Waksal is the director & President & CEO of Kadmon Holdings Inc. Other key executives at Kadmon Holdings Inc include Executive Vice President & CMO John L Ryan , EVP & Chief Financial Officer Steven Meehan , and EVP & General Counsel & Chief Compliance Officer Gregory S. Moss .
Kadmon Holdings Inc (KDMN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kadmon Holdings Inc (KDMN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kadmon Holdings Inc (KDMN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kadmon Holdings Inc (KDMN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kadmon Holdings Inc Insider Transactions
Harlan Waksal Mailing Address
Above is the net worth, insider trading, and ownership report for Harlan Waksal. You might contact Harlan Waksal via mailing address: Waksal Consulting Llc, 7 North Willow Street, Suite 6, Montclair Nj 07042.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
